↗7 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$837KSold on the market
1Companies
Oct 27, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202618:22 | Oct 23, 2026 | ROIVRoivant Sciences Ltd. | Director | F · Tax | $36.49 | −116 | 15,351 | -1% | $4K | ||
| Oct 27, 202618:22 | Oct 23, 2026 | ROIVRoivant Sciences Ltd. | Director | A · Grant | — | +513 | 15,467 | +3% | — | ||
| Oct 5, 202618:05 | Oct 1, 2026 | ROIVRoivant Sciences Ltd. | Director | S · Sell10b5-1 | $36.10 | −17,750 | 14,954 | -54% | −$641K | ||
| Oct 5, 202618:05 | Oct 1, 2026 | ROIVRoivant Sciences Ltd. | Director | M · Exercise10b5-1 | $4.46 | +17,750 | 32,704 | +119% | $79K | ||
| Sep 18, 202618:56 | Sep 16, 2026 | ROIVRoivant Sciences Ltd. | Director | A · Grant | — | +5,054 | 14,954 | +51% | — | ||
| Sep 17, 202618:43 | Sep 15, 2026 | ROIVRoivant Sciences Ltd. | Director | S · Sell10b5-1 | $39.74 | −4,938 | 9,900 | -33% | −$196K | ||
| Sep 14, 202618:34 | Sep 10, 2026 | ROIVRoivant Sciences Ltd. | Director | F · Tax | $40.94 | −2,179 | 14,838 | -13% | $89K |